Potential biomarker linked to multiple sclerosis progression and brain inflammation

Potential biomarker linked to multiple sclerosis progression and brain inflammation

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

New biomarker linked to multiple sclerosis progression and brain inflammation

Multiple sclerosis, often called MS, is a long-lasting disease that affects the brain and spinal cord. It happens when the body’s immune system mistakenly attacks the nervous system. This attack damages the protective coating around nerve cells, which slows or blocks messages between the brain and the rest of the body. Over time, this can […] The post New biomarker linked to multiple sclerosis progression and brain inflammation appeared first on…